We calculated the enrichment scores of tumor pathways using the ssGSEA based on the gene sets of oncogenic signaling pathways reported by Sanchez-Vega et al. We found that the high-risk group had higher scores in oncogenic signaling pathways such as the cell cycle, MYC, NOTCH, and RTK, while the low-risk group exhibited relatively higher activity in pathways including HIPPO, NRF2, PI3K, TGFβ, and TP53. The gene discussed is MYC; the disease is neoplasm.